Blue Bell Private Wealth Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.1K | Hold |
207
| – | – | ﹤0.01% | 529 |
|
|
2025
Q1 | $7.04K | Hold |
207
| – | – | ﹤0.01% | 542 |
|
|
2024
Q4 | $8.15K | Hold |
207
| – | – | ﹤0.01% | 516 |
|
|
2024
Q3 | $9.73K | Hold |
207
| – | – | ﹤0.01% | 528 |
|
|
2024
Q2 | $11.2K | Buy |
207
+75
| +57% | +$4.05K | ﹤0.01% | 510 |
|
|
2024
Q1 | $9K | Sell |
132
-80
| -38% | -$5.45K | ﹤0.01% | 531 |
|
|
2023
Q4 | $13.3K | Hold |
212
| – | – | ﹤0.01% | 463 |
|
|
2023
Q3 | $9.62K | Hold |
212
| – | – | ﹤0.01% | 426 |
|
|
2023
Q2 | $11.9K | Hold |
212
| – | – | ﹤0.01% | 397 |
|
|
2023
Q1 | $9.59K | Buy |
212
+50
| +31% | +$2.26K | ﹤0.01% | 382 |
|
|
2022
Q4 | $6.59K | Hold |
162
| – | – | ﹤0.01% | 423 |
|
|
2022
Q3 | $11K | Buy |
162
+10
| +7% | +$679 | ﹤0.01% | 356 |
|
|
2022
Q2 | $9K | Sell |
152
-30
| -16% | -$1.78K | ﹤0.01% | 387 |
|
|
2022
Q1 | $11K | Buy |
182
+69
| +61% | +$4.17K | ﹤0.01% | 391 |
|
|
2021
Q4 | $9K | Buy |
+113
| New | +$9K | ﹤0.01% | 414 |
|